Molecular insights into the mechanism of phenotypic tolerance to rifampicin conferred on mycobacterial RNA polymerase by MsRbpA

References

1. Artsimovitch I., Svetlov V., Anthony L., Burgess R. R., Landick R. ( 2000). RNA polymerases from Bacillus subtilis and Escherichia coli differ in recognition signal in vitro. J Bacteriol 182:6027–6035 [View Article][PubMed]
   [Google Scholar]
2. Artsimovitch I., Vassylyeva M. N., Svetlov D., Svetlov V., Perederina A., Igarashi N., Matsugaki N., Wakatsuki S., Tahirov T. H., Vassylyev D. G. ( 2005). Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins. Cell 122:351–363 [View Article][PubMed]
   [Google Scholar]
3. Bandwar R. P., Tang G. Q., Patel S. S. ( 2006). Sequential release of promoter contacts during transcription initiation to elongation transition. J Mol Biol 360:466–483 [View Article][PubMed]
   [Google Scholar]
4. Bhat J., Rane R., Solapure S. M., Sarkar D., Sharma U., Harish M. N., Lamb S., Plant D., Alcock P. et al. ( 2006). High-throughput screening of RNA polymerase inhibitors using a fluorescent UTP analog. J Biomol Screen 11:968–976 [View Article][PubMed]
   [Google Scholar]
5. Calleja C., Pascussi J. M., Mani J. C., Maurel P., Vilarem M. J. ( 1998). The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med 4:92–96 [View Article][PubMed]
   [Google Scholar]
6. Campbell E. A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., Darst S. A. ( 2001). Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901–912 [View Article][PubMed]
   [Google Scholar]
7. Cantor C. R., Schimmel P. R. ( 1980). Biophysical Chemistry433–463 San Francisco: Freeman;
   [Google Scholar]
8. Carpousis A. J., Gralla J. D. ( 1985). Interaction of RNA polymerase with lacUV5 promoter DNA during mRNA initiation and elongation. Footprinting, methylation, and rifampicin-sensitivity changes accompanying transcription initiation. J Mol Biol 183:165–177 [CrossRef]
   [Google Scholar]
9. Chatterji D., Gopal V. ( 1996). Fluorescence spectroscopy analysis of active and regulatory sites of RNA polymerase. Methods Enzymol 274:456–478
   [Google Scholar]
10. Dey A., Verma A. K., Chatterji D. ( 2010). Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin. Microbiology 156:873–883 [View Article][PubMed]
    [Google Scholar]
11. Flåtten I., Morigen, Skarstad K. ( 2009). DnaA protein interacts with RNA polymerase and partially protects it from the effect of rifampicin. Mol Microbiol 71:1018–1030 [View Article][PubMed]
    [Google Scholar]
12. Förster T. ( 1948). Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann. Physiol (Leipzig) 437:55–75 [View Article]
    [Google Scholar]
13. Gentry D. R., Burgess R. R. ( 1993). Cross-linking of Escherichia coli RNA polymerase subunits: identification of β′ as the binding site of ω. Biochemistry 32:11224–11227 [View Article][PubMed]
    [Google Scholar]
14. Hinkle D. C., Mangel W. F., Chamberlin M. J. ( 1972). Studies of the binding of Escherichia coli RNA polymerase to DNA. IV. The effect of rifampicin on binding and on RNA chain initiation. J Mol Biol 70:209–220 [View Article][PubMed]
    [Google Scholar]
15. Jain V., Sujatha S., Ojha A. K., Chatterji D. ( 2005). Identification and characterization of rel promoter element of Mycobacterium tuberculosis . Gene 351:149–157 [View Article][PubMed]
    [Google Scholar]
16. Jin D. J., Gross C. A. ( 1988). Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 202:45–58 [View Article][PubMed]
    [Google Scholar]
17. Kumar K. P., Chatterji D. ( 1990). Resonance energy transfer study on the proximity relationship between the GTP binding site and the rifampicin binding site of Escherichia coli RNA polymerase. Biochemistry 29:317–322 [View Article][PubMed]
    [Google Scholar]
18. Kumar K. P., Reddy P. S., Chatterji D. ( 1992). Proximity relationship between the active site of Escherichia coli RNA polymerase and rifampicin binding domain: a resonance energy-transfer study. Biochemistry 31:7519–7526 [View Article][PubMed]
    [Google Scholar]
19. Lakowicz J. R. ( 1983). Principles of Fluorescence Spectroscopy303–339 New York: Plenum Press;
    [Google Scholar]
20. Lee S. J., Gralla J. D. ( 2004). Osmo-regulation of bacterial transcription via poised RNA polymerase. Mol Cell 14:153–162 [View Article][PubMed]
    [Google Scholar]
21. Lisitsyn N. A., Sverdlov E. D., Moiseyeva E. P., Danilevskaya O. N., Nikiforov V. G. ( 1984). Mutation to rifampicin resistance at the beginning of the RNA polymerase beta subunit gene in Escherichia coli. . Mol Gen Genet 196:173–174 [CrossRef]
    [Google Scholar]
22. McClure W. R., Cech C. L. ( 1978). On the mechanism of rifampicin inhibition of RNA synthesis. J Biol Chem 253:8949–8956[PubMed]
    [Google Scholar]
23. Mukherjee R., Chatterji D. ( 2008). Stationary phase induced alterations in mycobacterial RNA polymerase assembly: a cue to its phenotypic resistance towards rifampicin. Biochem Biophys Res Commun 369:899–904 [View Article][PubMed]
    [Google Scholar]
24. Newell K. V., Thomas D. P., Brekasis D., Paget M. S. B. ( 2006). The RNA polymerase-binding protein RbpA confers basal levels of rifampicin resistance on Streptomyces coelicolor . Mol Microbiol 60:687–696 [View Article][PubMed]
    [Google Scholar]
25. Nudler E. ( 2009). RNA polymerase active center: the molecular engine of transcription. Annu Rev Biochem 78:335–361 [View Article][PubMed]
    [Google Scholar]
26. Opalka N., Brown J., Lane W. J., Twist K. A., Landick R., Asturias F. J., Darst S. A. ( 2010). Complete structural model of Escherichia coli RNA polymerase from a hybrid approach. PLoS Biol 14:8
    [Google Scholar]
27. Rabussay D., Zillig W. ( 1969). A rifampicin resistent RNA-polymerase from E. coli altered in the beta-subunit. FEBS Lett 5:104–106 [View Article][PubMed]
    [Google Scholar]
28. Stryer L. ( 1978). Fluorescence energy transfer as a spectroscopic ruler. Annu Rev Biochem 47:819–846 [View Article][PubMed]
    [Google Scholar]
29. Topal M. D., Fresco J. R. ( 1980). Fluorescence of terbium ion–nucleic acid complexes: a sensitive specific probe for unpaired residues in nucleic acids. Biochemistry 19:5531–5537 [View Article][PubMed]
    [Google Scholar]
30. Tyagi S. C., Wu F. Y.-H. ( 1987). Synthesis and characterization of fluorescent dinucleotide substrate for the DNA-dependent RNA polymerase from Escherichia coli . J Biol Chem 262:10684–10688[PubMed]
    [Google Scholar]
31. Węgrzyn A., Szalewska-Pałasz A., Błaszczak A., Liberek K., Węgrzyn G. ( 1998). Differential inhibition of transcription from σ⁷⁰- and σ³²-dependent promoters by rifampicin. FEBS Lett 440:172–174 [View Article][PubMed]
    [Google Scholar]
32. Wehrli W., Handschin J., Wunderli W. ( 1976). RNA Polymerase397–412 Chamberlin M. J., Losick R. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
33. Wichelhaus T., Schäfer V., Brade V., Böddinghaus B. ( 2001). Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus . J Antimicrob Chemother 47:153–156 [View Article][PubMed]
    [Google Scholar]
34. Williams D. L., Spring L., Collins L., Miller L. P., Heifets L. B., Gangadharam P. R., Gillis T. P. ( 1998). Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis . Antimicrob Agents Chemother 42:1853–1857[PubMed]
    [Google Scholar]
35. Wyss E., Wehrli W. ( 1976). The use of dextran-coated charcoal for kinetic measurements: interaction between rifampicin and DNA-dependent RNA polymerase of Escherichia coli . Anal Biochem 70:547–553 [View Article][PubMed]
    [Google Scholar]
36. Xu M., Zhou Y. N., Goldstein B. P., Jin D. J. ( 2005). Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics. J Bacteriol 187:2783–2792 [View Article][PubMed]
    [Google Scholar]
37. Yarbrough L. R., Wu F. Y., Wu C. W. ( 1976). Molecular mechanism of the rifampicin–RNA polymerase interaction. Biochemistry 15:2669–2676 [View Article][PubMed]
    [Google Scholar]
38. Yarbrough L. R., Schlageck J. G., Baughman M. ( 1979). Synthesis and properties of fluorescent nucleotide substrates for DNA-dependent RNA polymerases. J Biol Chem 254:12069–12073[PubMed]
    [Google Scholar]
39. Zenkin N., Kulbachinskiy A., Bass I., Nikiforov V. ( 2005). Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the β-subunit rifampin regions I and II. Antimicrob Agents Chemother 49:1587–1590 [View Article][PubMed]
    [Google Scholar]